Arm-to-retina time predicts visual outcome of anti-vascular endothelial growth factor treatment for macular edema due to central retinal vein occlusion

To explore the factors associated with best-corrected visual acuity (BCVA) after anti-vascular endothelial growth factor (anti-VEGF) treatment for macular edema secondary to central retinal vein occlusion (CRVO). We retrospectively reviewed the medical charts of 22 eyes of 22 treatment-naïve patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Takei, Tatsuhiko, Nagai, Norihiro, Ohkoshi, Kishiko, Ozawa, Yoko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828867/
https://www.ncbi.nlm.nih.gov/pubmed/35140311
http://dx.doi.org/10.1038/s41598-022-06281-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828867/
https://www.ncbi.nlm.nih.gov/pubmed/35140311
http://dx.doi.org/10.1038/s41598-022-06281-w

Ejemplares similares